LGM
KZR

Logos Global Management’s Kezar Life Sciences KZR Stock Holding History

Logos Global Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-95,000
Closed -$8.18M – 46
2022
Q3 		$8.18M Hold
95,000
– – 1.01% 26
2022
Q2 		$7.86M Sell
95,000
-66,402
-41% -$5.86M 1.44% 19
2022
Q1 		$26.8M Buy
161,402
+16,402
+11% +$2.35M 3.48% 14
2021
Q4 		$24.2M Sell
145,000
-265,000
-65% -$29.9M 2.5% 14
2021
Q3 		$35.4M Buy
410,000
+180,000
+78% +$11.9M 2.55% 16
2021
Q2 		$12.5M Buy
230,000
+150,000
+188% +$8.52M 1.05% 28
2021
Q1 		$4.77M Buy
+80,000
New +$4.68M 0.47% 34
2020
Q1 		– Sell
-12,293
Closed -$493K – 48
2019
Q4 		$493K Buy
+12,293
New +$378K 0.12% 40

Other funds holding KZR

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Logos Global Management's KZR Position: Q4 2022 in Review

Logos Global Management sold out of Kezar Life Sciences (KZR) in Q4 2022, closing a stake of 95,000 shares — an estimated $8.18M sold.

Logos Global Management first reported a position in KZR in Q4 2019 and held it in 8 quarters. The position peaked at $35.4M in Q3 2021. 121 funds tracked by Wall St. Rank hold KZR as of Q4 2022.

  • Logos Global Management reported no remaining Kezar Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Logos Global Management sold 95,000 Kezar Life Sciences shares in Q4 2022, an estimated $8.18M.
  • Logos Global Management first reported a position in Kezar Life Sciences in Q4 2019 and held it in 8 quarters.
  • Logos Global Management's Kezar Life Sciences position peaked at $35.4M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2022.

Based on Logos Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.